SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-241128
Filing Date
2018-08-07
Accepted
2018-08-07 16:17:18
Documents
54
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d483005d10q.htm 10-Q 738654
2 EX-31.1 d483005dex311.htm EX-31.1 6312
3 EX-31.2 d483005dex312.htm EX-31.2 6307
4 EX-32.1 d483005dex321.htm EX-32.1 3686
5 EX-32.2 d483005dex322.htm EX-32.2 3667
  Complete submission text file 0001193125-18-241128.txt   2755968

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dcph-20180630.xml EX-101.INS 358058
7 XBRL TAXONOMY EXTENSION SCHEMA dcph-20180630.xsd EX-101.SCH 33212
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dcph-20180630_cal.xml EX-101.CAL 47333
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dcph-20180630_def.xml EX-101.DEF 99785
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dcph-20180630_lab.xml EX-101.LAB 268447
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dcph-20180630_pre.xml EX-101.PRE 185667
Mailing Address 500 TOTTEN POND ROAD WALTHAM MA 02451
Business Address 500 TOTTEN POND ROAD WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38219 | Film No.: 18998315
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences